Eutelsat Group (ETL)
London Exchange · UK · prices in EUR · close of 20 Oct 2026
Key indicators
| Last close | EUR 4.200 |
|---|---|
| 52-week range | 1.395 – 4.510 |
| Return, 1 month / 3 months | +0.0% / +0.0% |
| Return, 1 year / 3 years | +26.4% / −4.1% |
| Trend | Below its 200-day average |
| RSI (14) | 49 |
| Volatility (1 year) | 31.1% |
| Worst drawdown (1 year) | -12.3% |
| Average daily value traded | 0.51M EUR |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Eutelsat Group is a satellite communications operator based in France. It runs fleets of satellites in geostationary and low Earth orbits and uses them to deliver television broadcasting, broadband internet and data connectivity. Its customers include broadcasters, telecom operators, businesses, government agencies and maritime and aviation users who need coverage across wide regions. The group provides satellite capacity and managed connectivity services rather than consumer devices, serving markets in Europe, Africa, the Middle East, Asia and the Americas.
The shares are listed on the London Exchange in UK under the code ETL, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 4 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Eutelsat Group (ETL) trades on the London Exchange in UK. It last closed at EUR 4.200 on 20 October 2026.
Its price-based Market X-Ray is 59 out of 100 (a fair price profile), ranking 1,446 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 26.4% and over the last three months it rose 0.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 60 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -0.7% | ||
| From 52-week high | -1.5% | ||
| Momentum | 57 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 0.0% | ||
| 6-month return | -1.5% | ||
| 12-month return, skipping the last month | 26.4% | ||
| Stability (higher is calmer) | 76 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 31.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -12.3% | ||
| Liquidity | 32 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.51M EUR | ||
| Zero-volume days | 35.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 2 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +0.0% |
|---|---|
| 1 month | +0.0% |
| 3 months | +0.0% |
| 6 months | −1.5% |
| 1 year | +26.4% |
| 3 years | −4.1% |
| 5 years | – |
Signals
| 50-day / 200-day average | 4.200 / 4.229 |
|---|---|
| Golden / death cross (60 days) | Death, 19 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.973 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 17 Nov 2022 | EUR 0.6624 |
| 16 Nov 2021 | EUR 0.6624 |
| 20 Nov 2020 | EUR 0.6339 |
| 21 Nov 2019 | EUR 0.9045 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.